期刊文献+

药物性肝病60例临床分析

Clinical analysis of 60 cases with drug-induced liver diseases
在线阅读 下载PDF
导出
摘要 目的分析60例药物性肝病临床特点,以利临床医生重视药物性肝病的预防、诊断与治疗,避免延误诊治。方法采用回顾性分析60例药物性肝病住院病人的用药史、临床表现、肝功能检查以及治疗转归作出综合分析。结果引起肝损害的药物中,以抗生素、抗肿瘤药物为主。药物性肝病的临床表现及肝功能检查与病毒性肝炎无明显差异,但合并有慢性肝炎的病人其病情较重。结论①引起药物性肝病的药物,以抗生素、抗肿瘤药多见,但中草药也不容忽视。②药物性肝病的临床表现为黄疸与转氨酶升高,与普通病毒性肝炎无明显特异性。经保肝、降酶、退黄治疗后,一般预后良好,但也可引起重症肝炎而死亡。③临床医师应重视药物性肝病的预防、诊断与治疗。 Objective To analyze the etiology and clinical features of 60 patients with drug-induced liver disease, and make clinical physicians attach importance to the prevention, diagnosis and treatment to avoid misdiagnosis. Methods Data of 60 patients with drug-induced liver disease, including the medication history, clinical manifestation, liver function tests ,treatment and short-term effect were reviewed retrospectively. Results There are a great variety of drugs causing drug-induced liver disease, mainly including antibiotics, antituberculotics and antineoplastics. Both the cases of drug-induced liver disease and the ones of virus hepatitis have no significant differences in the clinical manifestation and liver function tests, but the patients of chronic hepatitis tend to be more seriously ill. Conclusions ①There are various kinds of drugs causing drug-induced liver disease ,mainly including antibiotics, antituberculotics and antineoplastics. Moreover, herbs should not be ignored. ②The clinical manifestations of the patients of drug-induced liver disease are jaundice and the elevated ALT levels ,which have no significant differences with the ones of virus hepatitis. After the therapy of liver protection, ALT decrease and jaundice treatment, the patients usually get well. But some cases may cause severe hepatitis and death. ③Clinical physicians should attach importance to the prevention, diagnosis and treatment of drug-induced liver disease.
出处 《世界感染杂志》 2008年第1期64-65,72,共3页 World Journal of Infection
关键词 药物性肝病 病因 临床分析 drug-induced liver disease etiology clinical analysis
  • 相关文献

参考文献10

  • 1厉有名.药物性肝损害的临床类型及诊断策略[J].中华肝脏病杂志,2004,12(7):445-446. 被引量:252
  • 2Kaplowitz N. Drug-induced Liver disease: implications for drug development and regulation[J]. Durg Saf, 2001, 24(7): 483-490.
  • 3姚光弼.第十一讲 药物性肝病[J].中华消化杂志,1999,19(5):339-342. 被引量:133
  • 4Maria VAJ, victorino RMM. Development and Validation of a clinical Scale for the diagnosis of drug-induced hepatitis-Hepatololgy, 1997, 26: 664-669.
  • 5Speeg KV, Bay MK. Prevention and treatment of drug-induced liver disease[J]. Gastroenterol Clin North Am, 1995, 24(4): 1047-1064.
  • 6陈曦,梁冰.药物性肝炎52例临床分析[J].肝脏,2005,10(2):131-131. 被引量:10
  • 7许树梧,吴永佩主编.合理用药问答[M].长沙:湖南科学技术出版社,2004,57、58、87.
  • 8陈世耀,蒋晓渠,刘天舒,王吉耀.药物性肝病的病因和临床表现[J].中华肝脏病杂志,2000,8(4):244-244. 被引量:88
  • 9姚光弼 范上达 廖家杰.临床肝脏病学,2004,3(1):526-527.
  • 10Roy B, Chowdhury A, Kundu S, et al. Increased risk of antituberculosis durg induced hepatotoxicity in individuls with glutathiobne S-TRANSFERASE ML NULL MUTATION[J]. j Gastroenterol Hepatol, 2001, 16(9): 1033-1037.

二级参考文献5

  • 1Friedenberg F, Jensen G, Gujral N, et al. Serum albumin is predictive of 30-day survival after percutaneous endoscopic gastrostomy. JPEN, 1997,21:72-74.
  • 2Hoyumpa AM,Schenker S.Is glucuronidation truly preserved in patients with liver disease[].Hepatology.1991
  • 3Eisenberg DM,Kessler RC,Foster C,et al.Unconventional medicine in the United States. Prevalence, costs, and patterns of use[].New England Journal of Medicine The.1993
  • 4Van-Pelt FN,Straub P,Manns MP.Molecular basis of drug-induced immunological liver injury[].Seminars in Liver Disease.1995
  • 5刘平.中草药的肝损伤问题[J].中华肝脏病杂志,2004,12(4):243-243. 被引量:84

共引文献460

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部